Home / API Products / Exemestane
Exemestane
General information about the Exemestane active pharmaceutical ingredient
Exemestane as active pharmaceutical ingredient (API) is hormonal antineoplastic agent. Exemestane is a medication used to treat early and advance breast cancer in women after menopause. Exemestane comes as oral tablets. Exemestane is usually prescribed after the treatment with tamoxifen.
Therapeutic area
Anti-Cancer
Monograph
- PH.EUR.
- USP
Available grade
Micronized
Regulatory documentation
- CEP
- US DMF**
Produced in
GRO
Product Category
Steroids
Axplora manufactures Exemestane API
Exemestane API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Exemestane API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Exemestane API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Exemestane API.
We enable our partners to fully realize their ambitions.
Driven by the curiosity, skills and dedication of over 2,000 employees on three continents, Axplora delivers sustainable, technologically advanced API solutions to improve lives worldwide.